Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Neurofibromatosis and Schwannoma Cases

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on Neurofibromatosis Type 1 and Type 2, genetic disorders characterized by the development of tumors in the nervous system. The research covers various aspects including the role of tumor suppressor genes, Schwann cell origin of neurofibromas, cognitive deficits associated with the condition, and the molecular mechanisms underlying the disease.

144
Works

How has Neurofibromatosis and Schwannoma Cases's publication output changed over time?

ScholarIQpublication output · 2006–2022

Output grew0% over the shown period — from 1 works in 2006 to 1 in 2022.

1
1
1
1
2
1
2
1
2
1
2006200720082011201220162017202020212022

What are the most-cited papers on Neurofibromatosis and Schwannoma Cases?

ScholarIQmost cited works
Neurofibromatosis type 1
David H. Gutmann, Rosalie E. Ferner, Robert Listernick, Bruce R. Korf, Pamela L. Wolters, Kimberly Johnson
Nature Reviews Disease Primers. 2017848 Citations
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
Eric Legius, Ludwine Messiaen, P. Wolkenstein, Patrice Pancza, Robert A. Avery, Yemima Berman, Jaishri O. Blakeley, Dusica Babovic‐Vuksanovic, Karin Soares Cunha, Rosalie E. Ferner, Michael J. Fisher, Jan M. Friedman, David H. Gutmann, Hildegard Kehrer‐Sawatzki, Bruce R. Korf, Victor‐Felix Mautner, Sirkku Peltonen, Katherine A. Rauen, Vincent M. Riccardi, Elizabeth K. Schorry, Anat Stemmer‐Rachamimov, David A. Stevenson, Gianluca Tadini, Nicole J. Ullrich, David Viskochil, Katharina Wimmer, Kaleb Yohay, Alicia Gomes, Justin T. Jordan, Victor Mautner, Vanessa L. Merker, Miriam J. Smith, David A. Stevenson, Monique Anten, Arthur S. Aylsworth, Diana Baralle, S. Barbarot, Fred G. Barker, Shay Ben‐Shachar, Amanda L. Bergner, D. Bessis, Ignacio Blanco, Cathérine Cassiman, Patricia Ciavarelli, Maurizio Clementi, Thierry Frébourg, Marco Giovannini, Dorothy Halliday, Chris Hammond, C. Oliver Hanemann, Helen Hanson, Arvid Heiberg, K.H. Ly, Michel Kalamarides, Matthias A. Karajannis, Daniela Kroshinsky, Margarita Larralde, Conxi Lázaro, Lu Q. Le, Michael P. Link, Robert Listernick, Mia MacCollin, Conor Mallucci, Christopher L. Moertel, Amy Mueller, Joanne Ngeow, Rianne Oostenbrink, Roger J. Packer, Laura Papi, Allyson Parry, Juha Peltonen, Dominique C. Pichard, Bruce Poppe, Nilton Alves de Rezende, Luiz Oswaldo Carneiro Rodrigues, Tena Rosser, Martino Ruggieri, Eduard Serra, Verena Steinke‐Lange, Stavros Stivaros, Amy Taylor, Jaan Toelen, James H. Tonsgard, Eva Trevisson, Meena Upadhyaya, Ali Varan, Meredith Wilson, Hao Wu, Gelareh Zadeh, Susan Huson, D. Gareth Evans, Scott R. Plotkin
S187186932. 2021799 CitationsOPEN ACCESS
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
Chand Khanna, Xiaolin Wan, Seuli Bose, Ryan D. Cassaday, Osarenoma Olomu, Arnulfo Mendoza, Choh Yeung, Richard Görlick, Stephen M. Hewitt, Lee J. Helman
Nature Medicine. 2004720 Citations
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Andrea M. Gross, Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Patricia Whitcomb, Michael J. Fisher, Brian Weiss, AeRang Kim, Miriam Bornhorst, Amish C. Shah, Staci Martin, Marie Claire Roderick, Dominique C. Pichard, Amanda Carbonell, Scott M. Paul, Janet Therrien, Oxana B. Kapustina, Kara Heisey, D. Wade Clapp, Chi Zhang, Cody J. Peer, William D. Figg, Malcolm A. Smith, John Glod, Jaishri O. Blakeley, Seth M. Steinberg, David Venzon, L. Austin Doyle, Brigitte C. Widemann
New England Journal of Medicine. 2020714 CitationsOPEN ACCESS
Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh Marcus, Michael J. Fisher, Brian Weiss, AeRang Kim, Patricia Whitcomb, Staci Martin, Lindsey Aschbacher‐Smith, Tilat A. Rizvi, Jianqiang Wu, Rachel Ershler, Pamela L. Wolters, Janet Therrien, John Glod, Jean B. Belasco, Elizabeth K. Schorry, Alessandra Brofferio, Amy J. Starosta, Andrea Gillespie, Austin L. Doyle, Nancy Ratner, Brigitte C. Widemann
New England Journal of Medicine. 2016673 CitationsOPEN ACCESS

Where is Neurofibromatosis and Schwannoma Cases research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Neurofibromatosis and Schwannoma Cases is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
0%
Green
13%
Hybrid
13%
Bronze
33%
Closed
40%

Related on ScholarIQ

Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
Paper
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
Paper
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Paper
Genomic Analysis of Non- <i>NF2</i> Meningiomas Reveals Mutations in <i>TRAF7</i> , <i>KLF4</i> , <i>AKT1</i> , and <i>SMO</i>
Paper
Neurofibromatosis type 1
Paper
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
Paper
470M+ articles · free account